Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study
ard.bmj.com
Clinically Important Changes in AS with Tofacitinib
Three times as many patients on tofacitinib vs placebo had significant spine changes on MRI
medpagetoday.com
Tofacitinib provides ‘meaningful reduction’ in inflammation for patients with ankylosing spondylitis
healio.com
MRI Benefits Seen in AS for Xeljanz
More than 30% had clinically relevant improvement
medpagetoday.com
Treatment with Tofacitinib Is Associated with Clinically Meaningful Reductions in Axial MRI Inflammation in Patients with Ankylosing Spondylitis
Background/Purpose: Tofacitinib is an oral Janus…
acrabstracts.org